Servier
Fabien Schmidlin is an accomplished professional with extensive experience in the pharmaceutical and biotechnology sectors. Serving as Global Head of Translational Medicine at Servier from June 2019 to July 2020, Schmidlin previously held significant positions at IPSEN, including Head of Immuno & Inflammation Research and Vice President of Translational Sciences & Clinical Pharmacology. Prior experiences include roles as Vice President of Oncology & Biomarkers, Director of Translational Biology at Merck Group, Group Leader at AstraZeneca, and Senior Scientist at Pfizer, where Schmidlin demonstrated expertise in leading innovative research initiatives across various therapeutic areas.
This person is not in any teams
This person is not in any offices